MERIT MEDICAL SYSTEMS INC

For the period ended Sep 30, 2024. Filed Oct 30, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Oct 30, 2024

MMSI$88.42+1.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands)


· September 30, · December 31,
ASSETS · 2024 · 2023
	(unaudited)
Current assets: · ·
Cash and cash equivalents	$523,128	$587,036
Trade receivables — net of allowance for credit losses — 2024 — $9,266 and 2023 — $9,023	189,831	177,885
Other receivables	15,325	10,517
Inventories	310,527	303,871
Prepaid expenses and other current assets	27,105	24,286
Prepaid income taxes	4,216	4,016
Income tax refund receivables	8,185	859
Total current assets	1,078,317	1,108,470

Property and equipment:
Land and land improvements	26,108	26,017
Buildings	192,323	191,491
Manufacturing equipment	334,787	316,930
Furniture and fixtures	66,593	63,044
Leasehold improvements	59,005	53,638
Construction-in-progress	66,699	61,439
Total property and equipment	745,515	712,559
Less accumulated depreciation	(355,862)	(329,036)
Property and equipment — net	389,653	383,523

Other assets:
Intangible assets:
Developed technology — net of accumulated amortization — 2024 — $361,725 and 2023 — $321,488	322,325	283,999
Other — net of accumulated amortization — 2024 — $82,979 and 2023 — $76,887	49,839	41,884
Goodwill	399,448	382,240
Deferred income tax assets	7,253	7,288
Right-of-use operating lease assets	68,867	63,047
Other assets	62,382	54,793
Total other assets	910,114	833,251

Total assets	$2,378,084	$2,325,244


See condensed notes to consolidated financial statements.	(continued)

CONSOLIDATED BALANCE SHEETS

(In thousands)


· September 30, · December 31,
LIABILITIES AND STOCKHOLDERS’ EQUITY · 2024 · 2023
	(unaudited)
Current liabilities: · · ·
Trade payables	$60,808	$65,944
Accrued expenses	127,255	120,447
Short-term operating lease liabilities	11,469	12,087
Income taxes payable	1,547	5,086
Total current liabilities	201,079	203,564

Long-term debt	750,505	823,013
Deferred income tax liabilities	5,571	5,547
Long-term income taxes payable	347	347
Liabilities related to unrecognized tax benefits	1,912	1,912
Deferred compensation payable	19,218	17,167
Deferred credits	1,527	1,605
Long-term operating lease liabilities	57,178	56,259
Other long-term obligations	17,341	13,830
Total liabilities	1,054,678	1,123,244

Commitments and contingencies

Stockholders' equity:
Preferred stock — 5,000 shares authorized; no shares issued as of September 30, 2024 and December 31, 2023	—	—
Common stock, no par value — 100,000 shares authorized; issued and outstanding as of September 30, 2024 - 58,274 and December 31, 2023 - 57,858	669,207	638,150
Retained earnings	667,594	575,184
Accumulated other comprehensive loss	(13,395)	(11,334)
Total stockholders’ equity	1,323,406	1,202,000

Total liabilities and stockholders’ equity	$2,378,084	$2,325,244


See condensed notes to consolidated financial statements.	(concluded)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.